Insider Transactions

DAY HI:
DAY LOW:
VOLUME:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Insider Transactions

Date Name Title Type Shares Traded Price Range
Feb 23, 2021
Chief Legal Officer
Chief Legal Officer Other acquisition or disposition -- --
Feb 23, 2021
EVP, COO & CCO
EVP, COO & CCO Other acquisition or disposition -- --
Feb 23, 2021
Director, CEO & President
Director, CEO & President Other acquisition or disposition -- --
Feb 22, 2021
EVP & Chief Financial Officer
EVP & Chief Financial Officer Open market or private sale of non-derivative or derivative security 4,000 $3.73
Feb 22, 2021
Chief Legal Officer
Chief Legal Officer Open market or private sale of non-derivative or derivative security 4,000 $3.73
Feb 22, 2021
EVP, COO & CCO
EVP, COO & CCO Open market or private sale of non-derivative or derivative security 5,000 $3.73
Feb 22, 2021
Director, CEO & President
Director, CEO & President Open market or private sale of non-derivative or derivative security 7,500 $3.73
Feb 19, 2021
EVP & Chief Financial Officer
EVP & Chief Financial Officer Open market or private sale of non-derivative or derivative security 4,672 $3.64
Feb 19, 2021
Chief Legal Officer
Chief Legal Officer Open market or private sale of non-derivative or derivative security 3,295 $3.64
Feb 19, 2021
EVP, COO & CCO
EVP, COO & CCO Open market or private sale of non-derivative or derivative security 5,018 $3.64
Feb 19, 2021
Director, CEO & President
Director, CEO & President Open market or private sale of non-derivative or derivative security 7,257 $3.64
Feb 18, 2021
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 119,579 --
Feb 18, 2021
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 144,944 --
Feb 18, 2021
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 340,618 --
Feb 18, 2021
Chief Medical Officer
Chief Medical Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 110,309 --
Feb 18, 2021
Chief Medical Officer
Chief Medical Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 133,708 --
Feb 18, 2021
Chief Medical Officer
Chief Medical Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 314,213 --
Feb 18, 2021
Chief Legal Officer
Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 110,309 --
Feb 18, 2021
Chief Legal Officer
Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 133,708 --
Feb 18, 2021
Chief Legal Officer
Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 314,213 --
Feb 18, 2021
EVP, COO & CCO
EVP, COO & CCO Grant, award or other acquisition pursuant to Rule 16b-3(d) 134,410 --
Feb 18, 2021
EVP, COO & CCO
EVP, COO & CCO Grant, award or other acquisition pursuant to Rule 16b-3(d) 162,921 --
Feb 18, 2021
EVP, COO & CCO
EVP, COO & CCO Grant, award or other acquisition pursuant to Rule 16b-3(d) 382,865 --
Feb 18, 2021
Director, CEO & President
Director, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 278,090 --
Feb 18, 2021
Director, CEO & President
Director, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 337,079 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.